Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HINT1 | P49773 | 1/20 | 0.55 |
| ▸ | HLCS | P50747 | 3/20 | 0.54 |
| ▸ | STING1 | Q86WV6 | 1/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.39 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3411906 | 0.81 | ADORA2A (0.50) | ADORA3ADORA2A | |
| SCHEMBL3411985 | 0.79 | ADORA2A (0.53) | ADORA3ADORA2A | |
| SCHEMBL11703712 | 0.76 | ADORA2A (0.54) | ADORA3ADORA2A | |
| SCHEMBL4138126 | 0.75 | HLCS (0.67) | HINT1HLCSSTING1 | |
| SCHEMBL20419033 | 0.75 | HLCS (0.60) | HINT1HLCSSTING1 | |
| SCHEMBL20419019 | 0.75 | HLCS (0.60) | HINT1HLCSSTING1 | |
| SCHEMBL6298549 | 0.75 | ADORA2A (0.53) | ADORA3ADORA2A | |
| SCHEMBL3409898 | 0.75 | ADORA2A (0.53) | ADORA3ADORA2A | |
| SCHEMBL23982212 | 0.75 | HLCS (0.77) | HINT1HLCS | |
| SCHEMBL6709382 | 0.75 | HLCS (0.77) | HINT1HLCS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070258921-A1 | PROCESS FOR DEPIGMENTING THE SKIN | L'OREAL (FR) | 2007-11-08 | — | — | US | claimed |
| US-20070237734-A1 | ANTI-WRINKLE COSMETIC COMPOSITION | L'OREAL (FR) | 2007-10-11 | — | — | US | claimed |
| US-20100168049-A1 | COMBINATION OF MONOSACCHARIDES AND ADENOSINE AND USE THEREOF | L'OREAL (FR) | 2010-07-01 | — | — | US | disclosed |
| US-20070258921-A1 | PROCESS FOR DEPIGMENTING THE SKIN | L'OREAL (FR) | 2007-11-08 | — | — | US | disclosed |
| US-20070237734-A1 | ANTI-WRINKLE COSMETIC COMPOSITION | L'OREAL (FR) | 2007-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070258921-A1 | PROCESS FOR DEPIGMENTING THE SKIN | TYR, CUTA, NQO1 | HINT1 1221/4885HLCS 3322/4885STING1 2379/4885 |
| US-20070237734-A1 | ANTI-WRINKLE COSMETIC COMPOSITION | ADORA2A, ADORA3, ADORA1 | HINT1 250/4885HLCS 3872/4885STING1 443/4885 |
| US-20100168049-A1 | COMBINATION OF MONOSACCHARIDES AND ADENOSINE AND USE THEREOF | ADORA2A, ADORA1, ADORA3 | HINT1 87/4885HLCS 3955/4885STING1 882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.